Rationale: Accurate, early identification of patients at risk for developing acute lung injury (ALI) provides the opportunity to test and implement secondary prevention strategies.
INTRODUCTION
Investigations of therapeutic interventions in Acute Lung Injury (ALI) and its more severe form, Acute Respiratory Distress Syndrome (ARDS) have concentrated on patients with established disease. Proven and effective treatments at that point are limited. Indeed many treatments targeting the mechanisms identified in promising preclinical studies have failed to improve patient outcomes. Failed trials likely result, in part, from delayed recognition of patients at risk and the subsequent development of the full-blown syndrome. (1) (2) (3) (4) (5) Preventing the development of ALI may be more effective in improving outcomes.
Unfortunately, delivering preventative ALI therapies to at-risk individuals has received little attention. Given that there are over 200,000 cases of ALI in the United States each year, any intervention decreasing the incidence of ALI will significantly impact the mortality, morbidity, and intensive care unit (ICU) utilization associated with this syndrome. (6) A major obstacle to any early intervention or preventive studies is our inability to anticipate which patients are likely to develop ALI. Epidemiologic data suggest that ALI is rarely present at the time of initial Emergency Department (ED) evaluation or hospital admission for high risk elective surgery, but develops over a period of hours to days in a subset of at risk patients. (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) Recent Spanish study reported that the vast majority of patients with predisposing conditions never develop ALI making the enrollment of unselected patients into ALI prevention studies neither feasible nor efficient. (10) Moreover, a large number of patients who ultimately would not develop ALI would be subjected to the risk and expense of a prevention strategy. Recent studies have identified several "risk modifiers" which may alter the likelihood of ALI development in patients Page 3 of 33 with predisposing conditions. These include alcohol abuse,(18-21), hypoalbuminemia, (22, 23) tachypnea,(14, 20) oxygen supplementation,(24) chemotherapy, (20, 25) obesity,(26) and diabetes mellitus, (14, 27) although whether these factors are independent of one another is unclear. The lack of a validated risk model that confirms and consolidates these risk modifiers prevents the systematic determination of a population at high risk for developing ALI and is a major limitation to studies aimed at prevention or early intervention in ALI.
A recent single center observational study (28) reported an ALI prediction model, the Lung Injury Prediction Score (LIPS), incorporating the risk factors and risk modifiers present at the time of hospital admission, before ALI onset. Our aim was to validate and refine the LIPS model in at risk patients identified early in the course of their illness, and to determine the contemporary attributable mortality of this important complication. We believe that our results will facilitate the design and conduct of future ALI prevention strategies. Some of the results of these studies have been previously reported in the form of an abstract(29).
Materials and Methods:

Study Design
The multi-center observational cohort study was approved by the Institutional Review Board at each participating institution. Patients were enrolled prospectively in 19 hospitals and retrospectively (after hospital discharge) in 3 hospitals over a 6-month period, beginning in
March 2009).
Study Patients
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Consecutive adult patients admitted to academic and community acute care hospitals were eligible for the study if they presented with one or more study defined ALI risk factors including sepsis, shock, pancreatitis, pneumonia, aspiration, high risk trauma or high risk surgery. Patients were excluded if ALI criteria were present at the time of the initial assessment, if they were transferred from an outside hospital, died in the ED, or were admitted for comfort or hospice care. Hospital readmissions during the study period were also excluded.
Data Collection
Baseline characteristics, including sociodemographics, comorbidities, and clinical variables, were collected during the first 6 hours after initial ED evaluation or preoperatively at the time of hospital admission for high risk elective surgery .
Predisposing conditions and ALI risk modifiers were identified a priori and were incorporated into the LIPS model predicting ALI development. Predisposing conditions included: high risk trauma,(14-16) high risk surgery, (11, 19, 30, 31) aspiration,(11, 14, 16, 32) sepsis,(10, 11, 15, 16) shock,(10, 33-35) pneumonia,(10, 11, 22, 36) and pancreatitis (10, (37) (38) (39) (40) (41) (42) . ALI risk modifiers included: alcohol abuse,(18-21), hypoalbuminemia, (22, 23), acidosis, (22) tachypnea,(14, 20) oxygen supplementation, (24) obesity,(26) chemotherapy, (20, 25) and diabetes mellitus(14, 27).
De-identified subject information was entered at each center into the secure, passwordprotected NIH supported web form (REDCap http://www.project-redcap.org). Electronic range checks and validation rules were utilized to eliminate erroneous data entry and artifacts in numeric values. Hospital admission logs were reviewed to minimize the possibility that patients with predisposing condition were missed. Investigators and study
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coordinators at each site reviewed structured online training for the ALI assessment and the definitions of each risk factor (see electronic data supplement) prior to study initiation.
Primary investigators from each site provided a written statement stating the responsibility for the quality control of data collection and entry. In the 3 hospitals that enrolled retrospectively the investigators followed the same protocol and definitions but data were collected after patient discharge.
Outcomes
The primary outcome was the development of ALI during the hospital stay. ALI was defined according to the standard American-European Consensus Conference (AECC) definition(43) as the development of acute, bilateral pulmonary infiltrates and hypoxemia (PaO 2 /FIO 2 <300 -ALI, PaO 2 /FIO 2 <200 -ARDS) in the absence of clinical signs of left atrial hypertension as the main explanation for pulmonary edema. Secondary outcomes included ICU and hospital mortality, and ICU and hospital length of stay.
Data analysis
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines(44) were followed in the design and reporting of this observational study.
Analyses were performed by data coordinating center at the Mayo Clinic. Data were summarized as number (%) and median (IQR). Frequency of ALI was calculated per number of patients presenting with predisposing condition at the time of hospital admission. Sample size was determined prior to beginning of the study; 300 outcomes (ALI cases) were required to determine a proportion of the model (i.e. sensitivity) of 0.80 with a precision of +/-0.04 (95%CI 0.76 to 0.84), requiring ~ 300 patients per center to reach the enrollment goal.
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The primary analysis consisted of a validation of the predictive ability of the LIPS model that was previously developed and validated in a single-center population-based cohort (28), see electronic data supplement. LIPS weighting points were adjusted based on logistic regression analysis results from a training data set (a random sample of 2500 patients from the cohort). The score was derived by doubling of parameter estimates rounded to the closest 0.5 taking into consideration results from previous studies and the number of patients exposed (to prevent 'data fitting' and increase the likelihood of replicability). The scores corresponding to very high parameter estimates derived from a small number of exposures (i.e. near-drowning) were adjusted downwards. The scores corresponding to parameter estimates that grossly deviated from previously published studies (10-28) were also adjusted (for example in the derivation cohort pancreatitis was observed as "protective" but the corresponding score was neutral). The model was subsequently independently validated in the remaining patients. Model discrimination was assessed by calculating the area under the Receiver Operating Characteristic curve (AUC).
Model calibration was assessed using the Hosmer and Lemeshow test statistic. The threshold score providing the best combination of sensitivity and specificity was determined by AUC analysis, and corresponding positive and negative predictive values, positive and negative likelihood ratios, and their 95% confidence intervals were calculated.
A sensitivity analysis was performed to determine the model performance at different cut off points.
In secondary analyses, we compared hospital mortality and length of stay between patients at risk who developed ALI and those who did not. To determine the mortality burden due to the development of ALI, we performed a logistic regression analysis Additional post-hoc analyses evaluating LIPS performance in patient subgroups are presented in the electronic data supplement. These include the exclusion of patients from the 3 centers which enrolled retrospectively, restricting the analysis to patients who were admitted to the ICU and mortality prediction. The frequency of ALI varied according to predisposing condition ( Figure 2 ) with the highest rate of ALI occurring after smoke inhalation (26%) and the lowest rate occurring in pancreatitis (3%). Baseline characteristics and predisposing conditions and ALI risk modifiers (Table 1 ) differed between patients who did and those who did not develop ALI.
RESULTS
Between
The vast majority of patients had all measurements available at the time of hospital admission except for serum albumin (n=2423) and arterial pH (n=1499). As these tests are usually ordered based on clinical suspicion, missing data were considered normal (i.e. if serum albumin or arterial pH were not measured, hypoalbuminemia and acidosis were coded as absent), similarly to APACHE score calculation (45).
The weighting of LIPS points was adjusted based on the multivariate logistic regression analysis in the derivation cohort of 2500 randomly selected patients (Table 2) , and validated in the remaining (3084) patients. LIPS model calculation worksheet and the examples how to use it are presented in the Table 3 . LIPS model discriminated patients who developed ALI from those who did not with an AUC of 0.80 in the derivation cohort (95%CI 0.76 to 0.83), the validation cohort (95%CI 0.77 to 0.84), and in a combined data set (95%CI 0.78 to 0.82) composed of all study patients. The model was well calibrated in both training and testing datasets (Table E1 , electronic data supplement). Once validated, remaining analyses were performed in a combined data set. LIPS scores ranged from 0 to 15.5 (median 2.5). Outcome data for the study cohort are shown in Table 5 . Two thirds of the entire cohort and 91% of patients with ALI were treated in the ICU. Similarly, 40% of the entire cohort and 95% of patients with ALI were mechanically ventilated. Compared to at-risk patients who did not develop ALI, those who developed lung injury had increased mortality (23% vs 4%), and increased resource utilization as reflected in longer ICU (8 vs 2 days) and hospital (15 vs 6 days) lengths of stay. When adjusted for severity of illness using APACHE II score, and predisposing conditions (LIPS), the development of ALI markedly increased the risk of in-hospital death (OR 4.1, 95%CI 2.9-5.7) (Table E2 electronic data supplement). Table   E3 electronic data supplement)
DISCUSSION
In this multicenter cohort study, we refined and validated a prediction model to identify patients at high risk for ALI at the time of hospital admission. The strengths of this study include the large sample size from a geographically diverse population of patients at both academic and community hospitals. Using routinely available clinical data, the LIPS identified patients at high risk for ALI early in the course of their illness and before ICU admission. The early identification and subsequent intervention to prevent or minimize secondary injury may affect disease progression and further clinical deterioration. Importantly, this model will facilitate enrollment of patients into future mechanistic studies and ALI prevention trials.
The frequency of ALI for many known risk factors such as shock, pneumonia, and sepsis found in this study is lower than rates reported in prior studies. (11, 14, 16) The LIPS model has several strengths and it is both unique and easy to perform. First, it includes clinical information strongly associated with ALI in multiple studies and readily available at the time of the admission. It uses information that is clearly defined and routinely available in the medical record and as part of usual care. Second, the model identifies at risk patients early in the course of illness and before ICU admission. Finally, the model also includes a previously understudied group of patients at high risk of ALI who undergo high risk elective (cardiothoracic) surgery. In clinical practice the LIPS model may potentially be used to alert the providers to patients at risk of ALI. While no specific intervention has been shown to prevent ALI in patients at risk, applying a model such as LIPS to identify high risk patients may alert physicians to avoid specific "second hit" hospital exposures such as blood product transfusions, amiodarone, high tidal volume mechanical ventilation, and aspiration. In fact, single center studies have shown a significant decrease in the incidence of ALI in association with changes in health care delivery (17). Given the high mortality associated with the development of ALI and the significant functional and cognitive impairment experienced by survivors of ALI, prevention of ALI may improve survival and long term functional outcomes better than interventions aimed at reducing mortality after development of ALI.
While ALI development markedly increased the risk of death, the observed mortality rate of 23% is lower then previously reported. The exclusion of patients with established ALI transferred from outside facilities, the inclusion of patients who did not require invasive mechanical ventilation and secular trends in ALI prognosis provide potential explanations for the observed findings. (54) measuring specific risk modifiers in all patients (serum albumin, pH), or using specifically designed questionnaires (for example, to precisely ascertain alcohol abuse). Unfortunately, adding sophisticated technology or additional data collection might also complicate the simplicity of using this tool in real practice environments, particularly in the ED. Addition of health care delivery factors such as fluid and transfusion management, duration of cardiopulmonary bypass, or mechanical ventilation would certainly increase the accuracy of the prediction model. However, the principal purpose of the proposed scoring system is to identify patients as early as possible so that the health care delivery factors could be modified with an ultimate goal of ALI prevention. Pre planned ancillary studies are ongoing to explore potential differences in development of ALI in different institutions.
Our inclusion criteria required the presence of at least one ALI risk factor at the time of hospital admission, potentially missing the patients who develop a risk factor later in the hospital stay. However, in a recent population-based study <1% of patients admitted to the hospital without any of ALI risk factors actually develop ALI (28). Finally, the screening was performed daily, precluding timing ALI onset more precisely. It is possible that a minority of the patients identified at high risk were already on the way to developing fullblown ALI at the time of enrollment. We do believe however that earlier identification of such patients can limit the progression of ALI and improve patient outcomes by alerting providers to limit second-hit exposures.
Despite these limitations, the LIPS model discriminates efficiently between those patients who have a low risk of developing ALI while maintaining an appropriate sensitivity for a screening tool (negative predictive value of 0.97). By identifying the patients at higher risk of ALI the LIPS score may greatly enhance the feasibility of mechanistic studies and ALI prevention trials. For example the sample size requirements for a clinical trial of ALI/ARDS prevention of an effective intervention that was shown in preclinical studies to halve the risk of ALI/ARDS development (relative risk reduction of 50%) is much higher without (1778 total, 889 per group) than with (564 total, 282 per group) selecting high risk patients based on LIPS model.
In conclusion, our study is one of the largest available multicenter studies examining the clinical predictors for development of ALI in a diverse group of patients. This allowed us to develop and validate a simple tool to screen for patients at risk for ALI at the time of initial Emergency Department assessment or hospital admission for high-risk elective surgery. Given the fact that the majority of patients with predisposing conditions never develop ALI and are never admitted to the ICU, utilizing our prediction model will facilitate the identification of patients who can benefit from interventions to prevent disease progression, and also aid the timely and efficient enrollment of patients into future ALI prevention trials. LIPS performance was similar in different subgroup analyses: i.e. exclusion of patients who developed ALI/ARDS during the first 24 hours (6-24 hours) or after 5 days were excluded (full lines); exclusion of patients who developed ALI/ARDS during the first 48 hours (dashed line). The day of admission is marked as "day 0" and the second day as "day 1". The dashed line is at the end of "day1" (48hours). 7.4 (7.3, 7.4) 7.4 (7.3, 7.4) 7.3 (7.3, 7.4 
